Chemoinformaics analysis of Sesquiterpene II alcohol diglucoside (Compound 1)
| Molecular Weight | 546.654 | nRot | 7 |
| Heavy Atom Molecular Weight | 500.286 | nRig | 23 |
| Exact Molecular Weight | 546.304 | nRing | 4 |
| Solubility: LogS | -2.483 | nHRing | 2 |
| Solubility: LogP | 0.599 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 84 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 38 | No. of Aromatic Carbocycles | 0 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 0 |
| nHA | 11 | APOL | 84.5845 |
| nHD | 7 | BPOL | 53.0915 |
| QED | 0.203 |
| Synth | 5.216 |
| Natural Product Likeliness | 2.096 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.157 |
| HIA | 0.96 |
| CACO-2 | -5.239 |
| MDCK | 0.000211486 |
| BBB | 0.16 |
| PPB | 0.783028 |
| VDSS | 0.465 |
| FU | 0.144785 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.067 |
| CYP2c19-inh | 0.002 |
| CYP2c19-sub | 0.155 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.121 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.107 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.057 |
| CL | 1.128 |
| T12 | 0.139 |
| hERG | 0.026 |
| Ames | 0.125 |
| ROA | 0.107 |
| SkinSen | 0.014 |
| Carcinogencity | 0.088 |
| EI | 0.005 |
| Respiratory | 0.038 |
| NR-Aromatase | 0.009 |
| Antiviral | Yes |
| Prediction | 0.725905 |